About Interon Laboratories
Interon Laboratories is a Healthcare company based in Newton (United States) founded in 2020 by Jun Huh. Immunotherapies for neurological diseases are developed by the company. Interon Laboratories offers products and services including Neuro-Immunotherapy, Biologics Programs, and Small Molecule Therapeutics. Its focus areas include Life Sciences, Neurology, Drugs and Diversified. Its competitors include Biogen, Neurocrine and PTC Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Interon Laboratories was founded in 2020 in Newton, United States, within the biotechnology sector. Focus is placed on biologics and small molecule therapeutics to address neurological and immune disorders. The neuro-immune axis pathway is modulated through these treatments. Operations center on research and development of immunotherapies, with potential applications in mitigating related conditions. Leadership includes co-founder Jun Huh.
- Headquarters Newton, United States
- Founders Jun Huh
- SectorsHealthcare
- Email••••••••
- Website interonlabs.com
- Social LinkedIn
- Investors
Products & Services of Interon Laboratories
Interon Laboratories offers a comprehensive portfolio of products and services, including Neuro-Immunotherapy, Biologics Programs, and Small Molecule Therapeutics.
Combines neurobiology and immunology for non-invasive treatments.
Develops biologics to mitigate neurological disorders.
Targets immune disorders with innovative molecules.
Funding Insights of Interon Laboratories
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Interon Laboratories with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2023 | Seed | – | – |
1 investors in total: 1 institutional.
Investors in Interon Laboratories
Interon Laboratories has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Hanall Biopharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biopharmaceutical firm developing drugs for ophthalmology, immunology, oncology, and neurology. | 1973 | hanall.com | Seoul, South Korea |
Investor details for Interon Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Interon Laboratories
2 people are tracked at Interon Laboratories (2 in leadership).
| Name | Role | Group |
|---|---|---|
Jun Huh | Co-Founder | Leadership |
Jaspaul (Paul) Singh | Co-Founder, CEO | Leadership |
Complete people profiles for Interon Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Interon Laboratories
2 dated milestones of Interon Laboratories across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Interon Laboratories is founded.
- Funding First funding round.
Competitors of Interon Laboratories
Interon Laboratories has 3 listed competitors in our database, 3 of them funded. They include Biogen, Neurocrine and PTC Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biogen.com | 1978 | Cambridge, United States | $80M | 1 | Therapies for neurodegenerative and immunology disorders are developed. | |
| neurocrine.com | 1992 | San Diego, United States | $10M | 1,400 | Developer of small molecule therapeutics for endocrine and CNS disorders | |
| ptcbio.com | 1998 | South Plainfield, United States | $248.1M | 995 | Small molecule drugs for rare diseases are developed. |
Detailed competitors of Interon Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Neurology
3 companies that operate in the same segment as Interon Laboratories (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Interon Laboratories
Complete news archive for Interon Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Interon Laboratories
Interon Laboratories was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Interon Laboratories is headquartered in Newton, United States. It is registered at Newton, Massachusetts, United States.
Interon Laboratories was founded in 2020 in Newton, United States, within the biotechnology sector. Focus is placed on biologics and small molecule therapeutics to address neurological and immune disorders. The neuro-immune axis pathway is modulated through these treatments. Operations center on research and development of immunotherapies, with potential applications in mitigating related conditions. Leadership includes co-founder Jun Huh.
Interon Laboratories's top competitors include PTC Therapeutics, Neurocrine and Biogen.
Interon Laboratories offers Neuro-Immunotherapy, Biologics Programs, and Small Molecule Therapeutics.
Interon Laboratories has 1 investor. Key investors include Hanall Biopharma.